Neurones S.A. (0GX2)
LSE
39.05
+0.45 (+1.17%)
Closed
Nov 4, 2026
Day's Range
38.7539.05
52 wk Range
32.4544.85
Financial Statements - 0GX2 - Neurones S.A.
Revenue
130.85M▲ 42.4%
Net Income
-54.37M▲ 9.2%Net Margin -41.6%
EBITDA
-45.41M▲ 15.1%
Free Cash Flow
-34.83M▲ 17.8%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 130.85M | 91.92M | 74.64M | 60.90M |
| Cost of Goods | 63.47M | 41.15M | 33.41M | 31.63M |
| Gross Profit | 67.38M | 50.76M | 41.23M | 29.27M |
 Operating Expense | - | - | - | - |
| Operating Income | -48.93M | -58.33M | -66.22M | -54.98M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | -198K | 2.50M | 1.31M | 1.66M |
| Pre Tax Income | -54.05M | -59.57M | -70.98M | -57.33M |
| Income Tax | 319K | 284K | 263K | 229K |
| Net Income | -54.37M | -59.85M | -71.24M | -57.56M |
| EPS Basic | -0.32 | -0.37 | -0.51 | -0.44 |
| EPS Diluted | -0.32 | -0.37 | -0.51 | -0.44 |
| Basic Shares Outstanding | 171.27M | 163.94M | 139.83M | 131.66M |
| Diluted Shares Outstanding | 171.27M | 163.94M | 139.83M | 131.66M |
| Ebit | - | - | - | - |
| Ebitda | -45.41M | -53.51M | -62.42M | -51.79M |
| Net Income Continuous Operations | -54.37M | -59.85M | -71.24M | -57.56M |
| Minority Interests | 2K | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
